Here, we present a protocol for the preparation of two different forms of culture substrates utilizing type I collagen. Depending on how collagen is handled, collagen molecules either maintain two-dimensional, non-fibrous form or reassemble into three-dimensional, fibril form. Cell proliferation on type I collagen is drastically affected by fibril formation.
Type I collagen, useful as a substrate for cell culture, exists in two forms: the two-dimensional, non-fibrous form and three-dimensional, fibril form. Both forms can be prepared with the same type I collagen. In general, the non-fibrous form promotes cell adhesion and proliferation. The fibril form (gels) provides more physiological conditions in many types of cells; therefore, gel culture is useful for examining physiological behaviors of cells, such as drug efficacy.
Researchers can select the appropriate form according to the purpose of its use. For example, in the case of keratinocytes, on-gel culture has been used as a wound healing model. FEPE1L-8, a keratinocyte cell line cultured on the non-fibrous form of type I collagen, promote cell adhesion. Notably, keratinocyte proliferation is slower on the fibril form than the non-fibrous form. Protocols for the preparation of type I collagen for cell culture are simple and have wide applications depending on the experimental needs.
Interstitial connective tissues comprise a three-dimensional protein meshwork of heterogeneous composition, primarily composed of type I collagen fibrils1. Collagen fibrils play a key role as a scaffold for cells1,2,3 and interact with other extracellular matrix (ECM) proteins3. In vitro, different forms of type I collagen can be used as substrates for cell culture depending on the handling method1,2,3,4. Under acidic conditions, type I collagen maintains the non-fibrous form5. Coating the surface of culture dishes with the non-fibrous form promotes cell adhesion and proliferation6,7. At physiological pH and temperature, type I collagen molecules reassemble into fibrils that form gels possessing a three-dimensional structure1,2,3,4,5,6,7,8. There are several important differences between the fibril and non-fibrous forms of type I collagen, including matrix stiffness and efficiencies of reconstruction of ECM components by the cells during the culture1. Matrix stiffness is one of the most studied regulatory factors of cell culture1, 9. However, the complex interactions between substrates and cells remain to be clarified. To examine the complex interactions between cells and environmental factors, a simple system is useful. Comparison of the cellular behavior on the two different forms of collagen may help to simplify the effect of environmental factors. Depending on the purpose of their use, different forms of type I collagen can be selectively used. Normally, keratinocytes are in contact with the basement membrane but not with type I collagen. However, during wound healing, keratinocytes move to the dermal connective tissue, proliferate, and heal the wound10.
Recently, we demonstrated that the concentration of extracellular calcium is important for proliferation of keratinocyte line cells by using the culture system on the fibril form of type I collagen mimicking the dermal connective tissue11. When the keratinocyte cell line FEPE1L-8 was cultured on the fibril form of type I collagen, the shape of the cells was round and their proliferations were stopped at an extracellular calcium concentration of 30 μM11. When the calcium concentration was increased to 1.8 mM, cell growth was recovered11. The cells grew under both calcium concentrations (30 μM and 1.8 mM) when cultured on the non-fibrous form11, whereas they were more sensitive to the exogenous calcium concentration when cultured on the fibril form. FEPE1L-8 was generated through transfection with the papillomavirus type 16 transforming genes E6 and E7 from human cervical carcinoma, non-tumorigenic, inhibit unlimited proliferation with limited differentiation potential like normal keratinocytes12,13. FEPE1L-8 cells can be maintained by using some kinds of keratinocyte specific medium, including K110 Type-II with additive supplement K-1 (K110)6. Here, we describe the culture protocol of the human keratinocyte cell line on the non-fibrous and fibril forms of type I collagen.
1. Preparation of keratinocyte culture medium
NOTE: Perform all procedures under aseptic conditions.
2. Preparation of the fibril form of type I collagen
NOTE: Perform procedures until step 2.6 under aseptic conditions.
3. Preparation of the non-fibrous form of type I collagen
NOTE: Perform all procedures under aseptic conditions.
4. Culture of FEPE1L-8 cells
NOTE: Perform all procedures under aseptic conditions.
5. Estimation of the number of viable cells
A schematic representation of the treatment of the surfaces of culture dishes using type I collagen is depicted in Figure 1. Cell morphologies observed on the non-fibrous and fibril forms are presented in the left- and right-side panels of Figure 2, respectively. FEPE1L-8 cells were cultured for 2 h (upper panels) and 3 days (lower panels). In the initial 2 h of culturing, the cells adhered and spread on both forms of collagen (Figure 2, upper panels). Three days after seeding, cells on the non-fibrous form continued to spread and cell numbers increased (Figure 2, lower left panel). In contrast, the cells on the fibril form showed limited spreading (Figure 2, lower right panel). FEPE1L-8 cells continued to proliferate on the non-fibrous form of type I collagen (Figure 3, solid black line, closed black circles) and on the untreated dish surfaces (Figure 3, dotted gray line, closed gray circles). In contrast, cells did not proliferate on the fibril form (Figure 3, dotted line, open circles). Figure 2 and Figure 3 have been modified from Fujisaki et al11.
Figure 1: Schematic representations of culture dish surfaces treated with type I collagen. Under acidic conditions, type I collagen molecules are adsorbed on the surface of a dish in the non-fibrous form (left panel). Under neutral conditions at 37 °C, type I collagen molecules are reassembled into fibrils and adsorbed on the surface of dishes in the gel form (right panel). Please click here to view a larger version of this figure.
Figure 2: Morphology of FEPE1L-8 cells. FEPE1L-8 cells in K110 were cultured using the non-fibrous form (10 µg/mL; left panels) or fibril form (1 mg/mL; right panels) of type I collagen for 2 h (upper panels) or 3 days (lower panels). White bars indicate 100 µm. Figure 2 has been modified from Fujisaki et al. in Figure 1E–H11. Please click here to view a larger version of this figure.
Figure 3: Proliferation of FEPE1L-8 cell. The number of viable cells were estimated on the non-fibrous form (black solid line, black filled circles) or on the fibril form (dotted line, open circle) of type I collagen, or untreated dish surfaces (gray dotted line, gray filled circles) for 2 h, 1 day, and 3 days. Experiments were performed in triplicates and values are shown as means + SD. This figure has been modified from Fujisaki et al. in Figure 1J11. Please click here to view a larger version of this figure.
Some ECM components, including type I collagen, form three-dimensional structures in vivo1. Culturing on such a three-dimensional, gel substrate provides more physiological conditions in vitro than on a two-dimensional, plastic surface1,2,3,4. Numerous protocols regarding the gel culture method have been reported, such as using type I collagen1,2,3,4,6,7,11, type IV collagen14,15, and Matrigel16. Type I collagen is a well-defined and widely used material because of its abundance and ease of handling. The features of purified type I collagen depend on the animal species, age, and purification methods5,17. Type I collagen can be purified using acetic acid and/or proteases, such as pepsin, papain, and proctase5,17. Acid-soluble collagen maintains amino-telopeptides and protease-soluble collagen are cleaved amino-telopeptides5,17. The reserved length of amino-telopeptides depends on the type of proteases, and the presence of telopeptides affects fibril morphology and gel strength5,17. The viscosity of acid-soluble collagen fibrils is greater than that of protease-treated collagens17. In this study, we used acid-soluble bovine type I collagen. Pepsin-solubilized collagen can also be used in this gel culture protocol; however, the gel strength is weaker17. These differences in materials can cause cell behavioral differences, but they are currently not well understood.
The gel culture protocol described in this study is very simple. Many modifications of this method have been reported. One possible modification for the culture of keratinocytes is to mimic the basement membrane. Type IV collagen gels may be better to keep a basement membrane-like substrate structure in vitro15,18. However, a long incubation period is required for the preparation of type IV collagen gels14,15,18. Instead, mixing type IV collagen with type I collagen gels can produce novel culture substrates (type I/type IV collagen hybrid gels)19. These hybrid gels are easy to handle, require a short time for gelation, and yield more basement membrane-like conditions for keratinocytes. On type I/type IV collagen hybrid gels, keratinocytes survive, form colonies, and induce terminal differentiation19. This hybrid method has versatile applications.
On-gel culture using type I collagen affects cancer cells. On the fibril form of type I collagen, Akt activation and growth of Caco-2 cells (a colon cancer cell line) are suppressed7. In addition, the growth of human melanoma cells (M24met) on the fibril form is arrested at the G1/S checkpoint20. Moreover, markedly increased levels of reactive oxygen species are observed in murine 3T3-L1 preadipocytes cultured on the fibril form. Furthermore, cell proliferation and migration are stimulated in opposite directions by the non-fibrous and fibril forms of type I collagen21.
The authors have nothing to disclose.
We are grateful to Dr. K. Sekiguchi (Institute for Protein Research, Osaka University), Dr. M. Yamada (Institute for Protein Research, Osaka University), Dr. T. Ikejima (China-Japan Research Institute of Medical and Pharmaceutical Sciences, Wuya College of Innovation, Shenyang Pharmaceutical University) and T. Hayashi (China-Japan Research Institute of Medical and Pharmaceutical Sciences, Wuya College of Innovation, Shenyang Pharmaceutical University) for helpful comments.
Albumin, from bovine serum (BSA) | Merck KGaA | A4503 | |
1 % BSA | Merck KGaA | A4503 | Dissolve 1 g of BSA powder in 100 mL of PBS (-) and filtrate |
Cell Counting Kit-8 | Dojindo Molecular Technologies, Inc. | 347-07621 | tetrazolium salt, 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H tetrazolium, monosodium salt (WST-8) |
Collagen type I (Acid soluble collgen) | Nippi Inc. | ASC-1-100-20 | from bovine (any other species available, concentration is 3.0 mg/mL |
disposable membrane filter unit DISMIC cellulose acetate | ADVANTEC Co., LTD. | 25CS020AS | 0.2 µm pore size |
human keratinocyte line cell FEPE1L-8 | Donated Dr.W.G. Carter (Fred Hutchinson Cancer Research Center, Seattle, WA) | ||
K-1 | Kyokuto Seiyaku Inc. | 28204 | additive supplement with 500 mg of BSA, 500 mg of bovine pituitarybody extracts, 2.5 mg of insulin, 0.05 µg of h-EGF and 5 mg of heparin |
K110 Type-II medium | Kyokuto Seiyaku Inc. | 28204 | keratinocyte basal culture medium |
K110 Type-II medium with K-1 and Penicillin-Streptomycin (K110) | Kyokuto Seiyaku Inc. | 28204 | Add 5 mL of Penicillin-Streptomycin and 10 mL of additive supplement (K-1) in 500 mL of K110 type-II keratinocyte basal culture medium |
PBS (-) | Merck KGaA | P-5368 | Dissolve 1 pouch of PBS (-) powder in 1000 mL of deionized water and filtrate |
10x PBS (-) | Merck KGaA | P-5368 | Dissolve 1 pouch of PBS (-) powder in 100 mL of deionized water and filtrate |
Penicillin-Streptomycin | MP Biomedicals, LLC | 1670049 | 10000 units/mL of penisillin G and 10,000μg/mL of streptmycin sulfate in physiological saline |
Phosphate bufferred saline BioPerformance CertiCertified, pH 7.4 | Merck KGaA | P-5368-10 pack | |
Trypsin from porcine pancreas | Merck KGaA | T4799 | |
0.05 % trypsin | Merck KGaA | T4799 | Dissolve 0.25 g of trypsin and 0.186 g of EDTA.2Na in 500 mL of PBS (-) and filtrate |
Trypsin inhibitor from soybean | FUJIFILM Wako Pure Chemical corporation | 202-20123 | |
Trypsin inhibitor | FUJIFILM Wako Pure Chemical corporation | 202-20123 | Dissolve 50 mg of trypsin inhibitor and 500 mg of BSA in 500 mL of PBS (-) and filtrate |